OKs For 16 New Drugs But EMA Holds Firm On Betrixaban & Abaloparatide No

The European Medicines Agency this month recommended EU marketing approval for a raft of products, including what could become Europe's first two biosimilar versions of the blockbuster drug, Neulasta.